首页 > 最新文献

Tissue antigens最新文献

英文 中文
Identification of a novel HLA-DRB1*14 allele, HLA-DRB1*14:143, by sequence-based typing. HLA-DRB1*14等位基因HLA-DRB1*14:143的序列分型鉴定
Pub Date : 2014-02-01
M R Huo, B Xi, Y Yu, D Li

The novel HLA-DRB1*14:143 allele differs from DRB1*14:10 by two nucleotide substitutions at positions 344 and 345 of exon 2.

新的HLA-DRB1*14:143等位基因与DRB1*14:10的不同之处在于外显子2的344和345位有两个核苷酸的替换。
{"title":"Identification of a novel HLA-DRB1*14 allele, HLA-DRB1*14:143, by sequence-based typing.","authors":"M R Huo,&nbsp;B Xi,&nbsp;Y Yu,&nbsp;D Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The novel HLA-DRB1*14:143 allele differs from DRB1*14:10 by two nucleotide substitutions at positions 344 and 345 of exon 2.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":" ","pages":"134-5"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40284295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin. 聚乙二醇化干扰素-α和利巴韦林治疗的慢性丙型肝炎患者HLA-B*15:02与贫血相关
Pub Date : 2012-11-01 Epub Date: 2012-08-30 DOI: 10.1111/j.1399-0039.2012.01956.x
C-W Tseng, Y-H Hsieh, C-K Chang, N-S Lai, T-H Hung, S-F Wu, K-C Tseng

To investigate the relationship between human leukocyte antigen (HLA) class I and II alleles and treatment-induced anemia in chronic hepatitis C (CHC) patients receiving combination therapy with pegylated interferon-α (PEG-IFN-α) and ribavirin (RBV). One hundred six naïve CHC patients (59 females and 47 males; mean age, 53.08 years) who underwent combination treatment were enrolled. The patients were considered positive for hemoglobin (Hb)-related side effects if the Hb concentrations dropped below 10 g/dl during PEG-IFN-α plus RBV treatment. The HLA-A, -B, -C, -DR, and -DQ loci were investigated by sequence-based genotyping. The effects of the clinical characteristics, virologic variables, and the HLA alleles on treatment-induced anemia were evaluated by a logistic regression analysis. Forty patients (37.7%) had Hb levels below 10 g/dl during the treatment course. Low baseline Hb levels and an advanced liver fibrosis stage were associated with decreases in Hb levels to below 10 g/dl. The occurrence of treatment-related anemia (Hb < 10 g/dl) was significantly associated with HLA-B*15:02 as shown by multivariate analysis (adjusted odds ratio, 8.13; 95% confidence interval: 1.19-55.70; P-value after Holm's procedure, 0.03). HLA-B*15:02 is associated with treatment-induced anemia in Taiwanese CHC patients receiving combination therapy with PEG-IFN-α plus RBV.

目的探讨聚乙二醇化干扰素-α (PEG-IFN-α)和利巴韦林(RBV)联合治疗慢性丙型肝炎(CHC)患者治疗性贫血与人白细胞抗原(HLA) I类和II类等位基因的关系。166例naïve CHC患者(女性59例,男性47例;平均年龄53.08岁,接受联合治疗。如果在PEG-IFN-α + RBV治疗期间Hb浓度低于10 g/dl,则认为患者血红蛋白(Hb)相关副作用呈阳性。HLA-A、-B、-C、-DR和-DQ基因座采用基于序列的基因分型方法进行检测。通过logistic回归分析评价临床特征、病毒学变量和HLA等位基因对治疗性贫血的影响。40例患者(37.7%)在治疗过程中Hb水平低于10 g/dl。低基线Hb水平和晚期肝纤维化阶段与Hb水平降至10 g/dl以下相关。多因素分析显示,治疗相关性贫血(Hb < 10 g/dl)的发生与HLA-B*15:02显著相关(校正优势比为8.13;95%置信区间:1.19-55.70;霍尔姆手术后的p值为0.03)。台湾CHC患者接受PEG-IFN-α + RBV联合治疗时HLA-B*15:02与治疗性贫血相关
{"title":"HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin.","authors":"C-W Tseng,&nbsp;Y-H Hsieh,&nbsp;C-K Chang,&nbsp;N-S Lai,&nbsp;T-H Hung,&nbsp;S-F Wu,&nbsp;K-C Tseng","doi":"10.1111/j.1399-0039.2012.01956.x","DOIUrl":"https://doi.org/10.1111/j.1399-0039.2012.01956.x","url":null,"abstract":"<p><p>To investigate the relationship between human leukocyte antigen (HLA) class I and II alleles and treatment-induced anemia in chronic hepatitis C (CHC) patients receiving combination therapy with pegylated interferon-α (PEG-IFN-α) and ribavirin (RBV). One hundred six naïve CHC patients (59 females and 47 males; mean age, 53.08 years) who underwent combination treatment were enrolled. The patients were considered positive for hemoglobin (Hb)-related side effects if the Hb concentrations dropped below 10 g/dl during PEG-IFN-α plus RBV treatment. The HLA-A, -B, -C, -DR, and -DQ loci were investigated by sequence-based genotyping. The effects of the clinical characteristics, virologic variables, and the HLA alleles on treatment-induced anemia were evaluated by a logistic regression analysis. Forty patients (37.7%) had Hb levels below 10 g/dl during the treatment course. Low baseline Hb levels and an advanced liver fibrosis stage were associated with decreases in Hb levels to below 10 g/dl. The occurrence of treatment-related anemia (Hb < 10 g/dl) was significantly associated with HLA-B*15:02 as shown by multivariate analysis (adjusted odds ratio, 8.13; 95% confidence interval: 1.19-55.70; P-value after Holm's procedure, 0.03). HLA-B*15:02 is associated with treatment-induced anemia in Taiwanese CHC patients receiving combination therapy with PEG-IFN-α plus RBV.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"424-30"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1399-0039.2012.01956.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30866462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Distinct HLA allele and haplotype distributions in four ethnic groups of China. 中国4个民族HLA等位基因和单倍型的不同分布。
Pub Date : 2012-11-01 DOI: 10.1111/tan.12007
Y Yao, L Shi, Y Tao, J K Kulski, K Lin, X Huang, H Xiang, J Chu, L Shi

Distinct human leukocyte antigen (HLA) allele and haplotype distributions occur in the northern and southern Han populations of China. However, different ethnic groups in China show limited regional distributions for many HLA alleles and haplotypes. Therefore, it is necessary and meaningful to study the differences in HLA allele and haplotype distribution for northern and southern ethnic groups of China. A total of 428 unrelated individuals from the Lisu, Nu, Tu and Yugur ethnic populations were genotyped for HLA-A, -B, -C and -DRB1 alleles using the PCR-Luminex typing method. The frequencies of HLA alleles and statistically inferred haplotypes were calculated. A total of 29 HLA-A, 54 HLA-B, 27 HLA-C and 41 HLA-DRB1 alleles were spread throughout these four populations with distinct allele and deduced haplotype frequencies between populations. Some alleles and deduced haplotypes exhibited significantly different distributions between northern (Tu and Yugur) and southern groups (Lisu and Nu). A phylogenetic tree and principal component analysis were used to compare the HLA polymorphism between our dataset and 19 other eastern and southeastern Asian populations. This analysis showed that Lisu and Nu belong to a cluster of southern ethnic groups, while Tu and Yugur are most closely related to other northern groups. Thus, distinct ethnic population histories were revealed by analyzing HLA allelic polymorphisms with the HLA profiles of the Lisu and Nu southern Chinese ethnic groups clearly different from the Tu and Yugur northern ethnic groups. The results will be useful for future association studies of infectious disease and contribute toward a more efficient search of organ/tissue matches for transplantation.

人类白细胞抗原(HLA)等位基因和单倍型在中国北部和南部汉族人群中有明显的分布。然而,许多HLA等位基因和单倍型在中国不同民族的区域分布有限。因此,研究中国南北民族HLA等位基因和单倍型分布的差异是必要和有意义的。采用聚合酶链反应- luminex分型方法,对来自傈僳族、努族、土族和裕固族人群的428例无亲缘关系个体进行HLA-A、-B、-C和-DRB1等位基因分型。计算HLA等位基因的频率和统计推断的单倍型。共有29个HLA-A等位基因、54个HLA-B等位基因、27个HLA-C等位基因和41个HLA-DRB1等位基因分布在这4个群体中,具有不同的等位基因和推断出的群体间单倍型频率。一些等位基因和推断的单倍型在北方(土族和裕固族)和南方(傈僳族和怒族)之间的分布有显著差异。采用系统发育树和主成分分析比较了我们的数据集与其他19个东亚和东南亚人群的HLA多态性。分析表明,傈僳族和怒族属于南方少数民族,而土族和裕固族与北方其他少数民族关系最为密切。因此,通过分析南方傈僳族、女族与北方土族、裕固族的HLA等位基因多态性,揭示了不同民族的人群历史。该结果将有助于未来传染病的关联研究,并有助于更有效地寻找器官/组织移植匹配。
{"title":"Distinct HLA allele and haplotype distributions in four ethnic groups of China.","authors":"Y Yao,&nbsp;L Shi,&nbsp;Y Tao,&nbsp;J K Kulski,&nbsp;K Lin,&nbsp;X Huang,&nbsp;H Xiang,&nbsp;J Chu,&nbsp;L Shi","doi":"10.1111/tan.12007","DOIUrl":"https://doi.org/10.1111/tan.12007","url":null,"abstract":"<p><p>Distinct human leukocyte antigen (HLA) allele and haplotype distributions occur in the northern and southern Han populations of China. However, different ethnic groups in China show limited regional distributions for many HLA alleles and haplotypes. Therefore, it is necessary and meaningful to study the differences in HLA allele and haplotype distribution for northern and southern ethnic groups of China. A total of 428 unrelated individuals from the Lisu, Nu, Tu and Yugur ethnic populations were genotyped for HLA-A, -B, -C and -DRB1 alleles using the PCR-Luminex typing method. The frequencies of HLA alleles and statistically inferred haplotypes were calculated. A total of 29 HLA-A, 54 HLA-B, 27 HLA-C and 41 HLA-DRB1 alleles were spread throughout these four populations with distinct allele and deduced haplotype frequencies between populations. Some alleles and deduced haplotypes exhibited significantly different distributions between northern (Tu and Yugur) and southern groups (Lisu and Nu). A phylogenetic tree and principal component analysis were used to compare the HLA polymorphism between our dataset and 19 other eastern and southeastern Asian populations. This analysis showed that Lisu and Nu belong to a cluster of southern ethnic groups, while Tu and Yugur are most closely related to other northern groups. Thus, distinct ethnic population histories were revealed by analyzing HLA allelic polymorphisms with the HLA profiles of the Lisu and Nu southern Chinese ethnic groups clearly different from the Tu and Yugur northern ethnic groups. The results will be useful for future association studies of infectious disease and contribute toward a more efficient search of organ/tissue matches for transplantation.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"452-61"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/tan.12007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30940106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Exploiting microRNA regulation for genetic engineering. 利用microRNA调控基因工程。
Pub Date : 2012-11-01 DOI: 10.1111/tan.12002
B Gentner, L Naldini

RNA interference (RNAi) has been a landmark discovery in science. A typical application is to knock down the expression of endogenous genes by delivering small interfering RNA (siRNA) into cells triggering the degradation of complementary mRNA. However, RNAi can also be exploited the other way round: making use of the huge diversity of endogenous microRNAs (miRNA), the expression of exogenously introduced genes tagged with artificial miRNA target sequences can be negatively regulated according to the activity of a given miRNA which can be tissue-, lineage-, activation- or differentiation stage specific. This has significantly expanded the regulatory potential of gene transfer vectors and will benefit both basic science and therapeutic applications. This review briefly introduces the reader to the technical basis for exploiting miRNA regulation, followed by a discussion of specific applications for miRNA-regulated vectors/viruses in basic research, gene- and virotherapy.

RNA干扰(RNAi)是科学上具有里程碑意义的发现。一个典型的应用是通过将小干扰RNA (siRNA)传递到细胞中触发互补mRNA的降解来降低内源性基因的表达。然而,RNAi也可以反过来利用:利用内源性microrna (miRNA)的巨大多样性,外源引入的标记有人工miRNA靶序列的基因的表达可以根据给定miRNA的活性进行负调控,这些miRNA可以是组织特异性的,谱系特异性的,激活特异性的或分化阶段特异性的。这极大地扩展了基因转移载体的调控潜力,并将有利于基础科学和治疗应用。本文简要介绍了利用miRNA调控的技术基础,然后讨论了miRNA调控载体/病毒在基础研究、基因和病毒治疗中的具体应用。
{"title":"Exploiting microRNA regulation for genetic engineering.","authors":"B Gentner,&nbsp;L Naldini","doi":"10.1111/tan.12002","DOIUrl":"https://doi.org/10.1111/tan.12002","url":null,"abstract":"<p><p>RNA interference (RNAi) has been a landmark discovery in science. A typical application is to knock down the expression of endogenous genes by delivering small interfering RNA (siRNA) into cells triggering the degradation of complementary mRNA. However, RNAi can also be exploited the other way round: making use of the huge diversity of endogenous microRNAs (miRNA), the expression of exogenously introduced genes tagged with artificial miRNA target sequences can be negatively regulated according to the activity of a given miRNA which can be tissue-, lineage-, activation- or differentiation stage specific. This has significantly expanded the regulatory potential of gene transfer vectors and will benefit both basic science and therapeutic applications. This review briefly introduces the reader to the technical basis for exploiting miRNA regulation, followed by a discussion of specific applications for miRNA-regulated vectors/viruses in basic research, gene- and virotherapy.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"393-403"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/tan.12002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30940104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry. 利用流式细胞术检测内皮前体细胞和淋巴细胞特异性补体固定和非固定抗体。
Pub Date : 2012-11-01 Epub Date: 2012-08-30 DOI: 10.1111/j.1399-0039.2012.01954.x
A AlMahri, J Holgersson, M Alheim

Donor human leukocyte antigen (HLA)-specific antibodies (Abs) with the ability to activate complement are associated with an increased risk of early Ab-mediated rejection (AMR) of kidney allografts. In recent years, also non-HLA Abs-binding endothelial cells have been shown to elicit early AMR. Donor-specific anti-endothelial cell Abs escape detection in the pre-transplant evaluation if only lymphocytes are used as target cells in crossmatch tests. We addressed whether endothelial precursor cells (EPCs) could be used for detection of complement-fixing as well as non-fixing Abs and if complement factor and immunoglobulin G (IgG) deposition on co-purified T and B cells correlated to the outcome of the T- and B-cell complement-dependent cytotoxicity assay. Deposition of complement factors C3c and C3d, but not C1q nor C4d, were detected on EPCs and lymphocytes upon incubation with HLA Ab-positive sera. There was a correlation between the amount of C3c deposition and IgG binding on EPCs (R(2) = 0.71, P = 0.0012) and T cells (R(2) = 0.74, P = 0.0006) but not for B cells (R(2) = 0.34, P = 0.059). The specificity and sensitivity for C3d deposition on endothelial precursor cell crossmatch (EPCXM) T cells vs the T complement-dependent cytotoxicity (CDC) assay were 69% and 72%, respectively. The EPCXM B-cell C3d assay had considerably lower sensitivity (39%) than the B CDC assay. Altogether, this novel assay based on the detection of complements factors on EPCs and lymphocytes by flow cytometry may widen the diagnostic repertoire and thereby improve the clinical management of patients undergoing kidney transplantation.

具有激活补体能力的供体人白细胞抗原(HLA)特异性抗体(Abs)与肾移植早期抗体介导的排斥反应(AMR)风险增加有关。近年来,非hla抗体结合的内皮细胞也被证明可引起早期AMR。如果在交叉配型试验中仅使用淋巴细胞作为靶细胞,则移植前评估中供体特异性抗内皮细胞抗体逃逸检测。我们研究了内皮前体细胞(EPCs)是否可以用于检测补体固定和非固定抗体,以及补体因子和免疫球蛋白G (IgG)沉积在共纯化的T细胞和B细胞上是否与T细胞和B细胞补体依赖性细胞毒性试验的结果相关。与HLA - ab阳性血清孵育后,EPCs和淋巴细胞上检测到补体因子C3c和C3d的沉积,但未检测到C1q和C4d的沉积。C3c沉积量与IgG结合在EPCs (R(2) = 0.71, P = 0.0012)和T细胞(R(2) = 0.74, P = 0.0006)有相关性,而与B细胞(R(2) = 0.34, P = 0.059)无相关性。与T补体依赖性细胞毒性(CDC)相比,内皮前体细胞交叉配型(EPCXM) T细胞上C3d沉积的特异性和敏感性分别为69%和72%。EPCXM B细胞C3d检测的灵敏度(39%)明显低于B CDC检测。总之,这种基于流式细胞术检测EPCs和淋巴细胞补体因子的新方法可能扩大诊断范围,从而改善肾移植患者的临床管理。
{"title":"Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.","authors":"A AlMahri,&nbsp;J Holgersson,&nbsp;M Alheim","doi":"10.1111/j.1399-0039.2012.01954.x","DOIUrl":"https://doi.org/10.1111/j.1399-0039.2012.01954.x","url":null,"abstract":"<p><p>Donor human leukocyte antigen (HLA)-specific antibodies (Abs) with the ability to activate complement are associated with an increased risk of early Ab-mediated rejection (AMR) of kidney allografts. In recent years, also non-HLA Abs-binding endothelial cells have been shown to elicit early AMR. Donor-specific anti-endothelial cell Abs escape detection in the pre-transplant evaluation if only lymphocytes are used as target cells in crossmatch tests. We addressed whether endothelial precursor cells (EPCs) could be used for detection of complement-fixing as well as non-fixing Abs and if complement factor and immunoglobulin G (IgG) deposition on co-purified T and B cells correlated to the outcome of the T- and B-cell complement-dependent cytotoxicity assay. Deposition of complement factors C3c and C3d, but not C1q nor C4d, were detected on EPCs and lymphocytes upon incubation with HLA Ab-positive sera. There was a correlation between the amount of C3c deposition and IgG binding on EPCs (R(2) = 0.71, P = 0.0012) and T cells (R(2) = 0.74, P = 0.0006) but not for B cells (R(2) = 0.34, P = 0.059). The specificity and sensitivity for C3d deposition on endothelial precursor cell crossmatch (EPCXM) T cells vs the T complement-dependent cytotoxicity (CDC) assay were 69% and 72%, respectively. The EPCXM B-cell C3d assay had considerably lower sensitivity (39%) than the B CDC assay. Altogether, this novel assay based on the detection of complements factors on EPCs and lymphocytes by flow cytometry may widen the diagnostic repertoire and thereby improve the clinical management of patients undergoing kidney transplantation.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"404-15"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1399-0039.2012.01954.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30866158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Polymorphisms in the promoter of the CD14 gene and their associations with susceptibility to pulmonary tuberculosis. CD14基因启动子多态性及其与肺结核易感性的关系
Pub Date : 2012-11-01 Epub Date: 2012-09-03 DOI: 10.1111/j.1399-0039.2012.01958.x
Y Xue, Z Q Zhao, F Chen, L Zhang, G D Li, K W Ma, X F Bai, Y J Zuo

Although the role of CD14 in recognizing Mycobacterium tuberculosis is well-understood, the possible role of polymorphisms in susceptibility to develop tuberculosis remains unclear. This study evaluates whether there is an association of polymorphisms within the promoter of the CD14 gene with susceptibility to pulmonary tuberculosis. In a case-control study, we genotyped the eight known single nucleotide polymorphisms SNPs within the promoter of the CD14 gene of 698 Han Chinese subjects. Statistically significant differences between tuberculosis patients and healthy controls were found for G-1619A, T-1359G, A-1145G, and C-159T. The haplotype-GGGT, composed of these four SNPs, exhibited a significant association with the disease. Furthermore, expression levels of soluble CD14 were significantly higher in tuberculosis patients with the GGGT haplotype than with other haplotypes, while IgE expression levels were significantly reduced. Our results suggest that these four SNPs within the promoter of the CD14 gene are associated with susceptibility to pulmonary tuberculosis.

尽管CD14在识别结核分枝杆菌中的作用已被充分了解,但多态性在结核病易感性中的可能作用仍不清楚。本研究评估CD14基因启动子内的多态性是否与肺结核易感性相关。在一项病例对照研究中,我们对698名汉族受试者的CD14基因启动子内的8个已知单核苷酸多态性snp进行了基因分型。G-1619A、T-1359G、A-1145G和C-159T在结核病患者和健康对照组之间存在统计学差异。由这四个snp组成的单倍型gggt与该病有显著的相关性。GGGT单倍型结核患者可溶性CD14表达水平显著高于其他单倍型结核患者,而IgE表达水平显著降低。我们的研究结果表明,CD14基因启动子内的这四个snp与肺结核的易感性有关。
{"title":"Polymorphisms in the promoter of the CD14 gene and their associations with susceptibility to pulmonary tuberculosis.","authors":"Y Xue,&nbsp;Z Q Zhao,&nbsp;F Chen,&nbsp;L Zhang,&nbsp;G D Li,&nbsp;K W Ma,&nbsp;X F Bai,&nbsp;Y J Zuo","doi":"10.1111/j.1399-0039.2012.01958.x","DOIUrl":"https://doi.org/10.1111/j.1399-0039.2012.01958.x","url":null,"abstract":"<p><p>Although the role of CD14 in recognizing Mycobacterium tuberculosis is well-understood, the possible role of polymorphisms in susceptibility to develop tuberculosis remains unclear. This study evaluates whether there is an association of polymorphisms within the promoter of the CD14 gene with susceptibility to pulmonary tuberculosis. In a case-control study, we genotyped the eight known single nucleotide polymorphisms SNPs within the promoter of the CD14 gene of 698 Han Chinese subjects. Statistically significant differences between tuberculosis patients and healthy controls were found for G-1619A, T-1359G, A-1145G, and C-159T. The haplotype-GGGT, composed of these four SNPs, exhibited a significant association with the disease. Furthermore, expression levels of soluble CD14 were significantly higher in tuberculosis patients with the GGGT haplotype than with other haplotypes, while IgE expression levels were significantly reduced. Our results suggest that these four SNPs within the promoter of the CD14 gene are associated with susceptibility to pulmonary tuberculosis.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"437-43"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1399-0039.2012.01958.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30871662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis. CCR5基因多态性是类风湿关节炎放射学严重程度的遗传危险因素。
Pub Date : 2012-11-01 Epub Date: 2012-08-24 DOI: 10.1111/j.1399-0039.2012.01955.x
S W Han, K H Sa, S I Kim, S I Lee, Y W Park, S S Lee, W H Yoo, J S Soe, E J Nam, J Lee, J Y Park, Y M Kang

The chemokine receptor [C-C chemokine receptor 5 (CCR5)] is expressed on diverse immune effecter cells and has been implicated in the pathogenesis of rheumatoid arthritis (RA). This study sought to determine whether single-nucleotide polymorphisms (SNPs) in the CCR5 gene and their haplotypes were associated with susceptibility to and severity of RA. Three hundred fifty-seven patients with RA and 383 healthy unrelated controls were recruited. Using a pyrosequencing assay, we examined four polymorphisms -1118 CTAT(ins) (/del) (rs10577983), 303 A>G (rs1799987), 927 C>T (rs1800024), and 4838 G>T (rs1800874) of the CCR5 gene, which were distributed over the promoter region as well as the 5' and 3' untranslated regions. No significant difference in the genotype, allele, and haplotype frequencies of the four selected SNPs was observed between RA patients and controls. CCR5 polymorphisms of -1118 CTAT(del) (P = 0.012; corrected P = 0.048) and 303 A>G (P = 0.012; corrected P = 0.048) showed a significant association with radiographic severity in a recessive model, and, as a result of multivariate logistic regression analysis, were found to be an independent predictor of radiographic severity. When we separated the erosion score from the total Sharp score, the statistical significance of CCR5 polymorphisms showed an increase; -1118 CTAT(ins) (/del) (P = 0.007; corrected P = 0.028) and 303 A>G (P = 0.007; corrected P = 0.028). Neither SNPs nor haplotypes of the CCR5 gene showed a significant association with joint space narrowing score. These results indicate that genetic polymorphisms of CCR5 are an independent risk factor for radiographic severity denoted by modified Sharp score, particularly joint erosion in RA.

趋化因子受体[C-C趋化因子受体5 (CCR5)]在多种免疫效应细胞上表达,并与类风湿关节炎(RA)的发病机制有关。本研究旨在确定CCR5基因的单核苷酸多态性(snp)及其单倍型是否与RA的易感性和严重程度相关。357名RA患者和383名健康的非相关对照者被招募。利用焦磷酸测序技术,我们检测了CCR5基因的4个多态性-1118 CTAT(ins) (/del) (rs10577983)、303 a >G (rs1799987)、927 C>T (rs1800024)和4838 G>T (rs1800874),它们分布在启动子区以及5'和3'非翻译区。在RA患者和对照组之间,所选4个snp的基因型、等位基因和单倍型频率均无显著差异。-1118 CTAT(del)的CCR5多态性(P = 0.012;修正P = 0.048), 303 A>G (P = 0.012;校正P = 0.048)在隐性模型中显示与放射学严重程度显著相关,并且作为多变量logistic回归分析的结果,被发现是放射学严重程度的独立预测因子。将侵蚀评分与Sharp总分分离后,CCR5多态性的统计学显著性增加;-1118 CTAT(ins) (/del) (P = 0.007;修正P = 0.028), 303 A>G (P = 0.007;修正P = 0.028)。CCR5基因的snp和单倍型与关节间隙变窄评分均无显著相关性。这些结果表明,CCR5的遗传多态性是影像学严重程度的独立危险因素,尤其是关节炎的关节侵蚀。
{"title":"CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis.","authors":"S W Han,&nbsp;K H Sa,&nbsp;S I Kim,&nbsp;S I Lee,&nbsp;Y W Park,&nbsp;S S Lee,&nbsp;W H Yoo,&nbsp;J S Soe,&nbsp;E J Nam,&nbsp;J Lee,&nbsp;J Y Park,&nbsp;Y M Kang","doi":"10.1111/j.1399-0039.2012.01955.x","DOIUrl":"https://doi.org/10.1111/j.1399-0039.2012.01955.x","url":null,"abstract":"<p><p>The chemokine receptor [C-C chemokine receptor 5 (CCR5)] is expressed on diverse immune effecter cells and has been implicated in the pathogenesis of rheumatoid arthritis (RA). This study sought to determine whether single-nucleotide polymorphisms (SNPs) in the CCR5 gene and their haplotypes were associated with susceptibility to and severity of RA. Three hundred fifty-seven patients with RA and 383 healthy unrelated controls were recruited. Using a pyrosequencing assay, we examined four polymorphisms -1118 CTAT(ins) (/del) (rs10577983), 303 A>G (rs1799987), 927 C>T (rs1800024), and 4838 G>T (rs1800874) of the CCR5 gene, which were distributed over the promoter region as well as the 5' and 3' untranslated regions. No significant difference in the genotype, allele, and haplotype frequencies of the four selected SNPs was observed between RA patients and controls. CCR5 polymorphisms of -1118 CTAT(del) (P = 0.012; corrected P = 0.048) and 303 A>G (P = 0.012; corrected P = 0.048) showed a significant association with radiographic severity in a recessive model, and, as a result of multivariate logistic regression analysis, were found to be an independent predictor of radiographic severity. When we separated the erosion score from the total Sharp score, the statistical significance of CCR5 polymorphisms showed an increase; -1118 CTAT(ins) (/del) (P = 0.007; corrected P = 0.028) and 303 A>G (P = 0.007; corrected P = 0.028). Neither SNPs nor haplotypes of the CCR5 gene showed a significant association with joint space narrowing score. These results indicate that genetic polymorphisms of CCR5 are an independent risk factor for radiographic severity denoted by modified Sharp score, particularly joint erosion in RA.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"416-23"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1399-0039.2012.01955.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30860591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Identification of the novel HLA-A allele, HLA-A*24:96, in a Chinese individual. 中国人新型HLA-A等位基因HLA-A*24:96的鉴定
Pub Date : 2012-11-01 Epub Date: 2012-08-16 DOI: 10.1111/j.1399-0039.2012.01940.x
L Wang, Z Zhixin, S Xiaoyan, B Zhao, Z Gong

The human leukocyte antigen (HLA)-A*24:96 allele differs from the closest matching allele A*24:01:01:01 by three nucleotide substitutions in exon 3 at nt 411(C->T), nt 412(C->A) and nt 419(A->T).

人类白细胞抗原(HLA)-A*24:96等位基因在nt 411(C->T)、nt 412(C->A)和nt 419(A->T)外显子3的3个核苷酸替换上与最匹配的等位基因A*24:01:01不同。
{"title":"Identification of the novel HLA-A allele, HLA-A*24:96, in a Chinese individual.","authors":"L Wang,&nbsp;Z Zhixin,&nbsp;S Xiaoyan,&nbsp;B Zhao,&nbsp;Z Gong","doi":"10.1111/j.1399-0039.2012.01940.x","DOIUrl":"https://doi.org/10.1111/j.1399-0039.2012.01940.x","url":null,"abstract":"<p><p>The human leukocyte antigen (HLA)-A*24:96 allele differs from the closest matching allele A*24:01:01:01 by three nucleotide substitutions in exon 3 at nt 411(C->T), nt 412(C->A) and nt 419(A->T).</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"462-3"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1399-0039.2012.01940.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30838015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
MBL2 gene variation affecting serum MBL is associated with prosthetic joint infection in Czech patients after total joint arthroplasty. 影响血清MBL的MBL2基因变异与捷克患者全关节置换术后假体关节感染有关。
Pub Date : 2012-11-01 Epub Date: 2012-09-20 DOI: 10.1111/tan.12001
Z Navratilova, J Gallo, F Mrazek, J Lostak, M Petrek

Prosthetic joint infection (PJI) is a serious complication of the total joint arthroplasty (TJA). Serum mannose-binding lectin (MBL), a pattern recognition receptor, is involved in antibacterial immune response. This study investigated whether functional variants of the MBL2 gene may be associated with the risk of PJI. MBL2 -550 (H/L, rs11003125), MBL2 -221 (Y/X, rs7096206) and MBL2 +54 (G/A, rs1800450) single nucleotide polymorphisms (SNP) were genotyped in 112 PJI patients and two control groups: 245 patients with aseptic TJA and 196 Czech population controls without TJA. Serum MBL concentration was assessed in PJI patients (n = 92) and aseptic TJA controls (n = 56). The distribution of MBL2 genotypes complied with the Hardy-Weinberg equilibrium in all investigated groups. Importantly, MBL2 -550 L allele (allelic frequency, 0.72) and LL genotype (genotype frequency, 0.51) were more frequent among PJI patients compared to aseptic TJA controls (L allele: 0.63, P = 0.016, P(c) = 0.048; LL genotype: 0.39, P = 0.037, P(c) > 0.05) and to Czech population controls (L allele: 0.61, P = 0.010, P(c) = 0.030; LL genotype: 0.35, P = 0.006, P(c) = 0.018), respectively. Regarding MBL protein, the MBL2 -550 L carriers presented with lower serum MBL concentrations than non-carriers (median; 593 vs 1876 ng/ml; P < 0.01). Similarly, the carriage of MBL2 -221 X and 54 A alleles was associated with lower serum MBL concentrations (P < 0.01). In conclusion, MBL2 -550 genetic variant(s) associated with low serum concentration of MBL protein can increase the risk of PJI.

人工关节感染(PJI)是全关节置换术(TJA)的严重并发症。血清甘露糖结合凝集素(MBL)是一种模式识别受体,参与抗菌免疫应答。本研究调查了MBL2基因的功能变异是否可能与PJI的风险相关。MBL2 -550 (H/L, rs11003125)、MBL2 -221 (Y/X, rs7096206)和MBL2 +54 (G/A, rs1800450)单核苷酸多态性(SNP)在112例PJI患者和2个对照组中进行基因分型:245例无菌性TJA患者和196例捷克非TJA人群对照。评估PJI患者(n = 92)和无菌TJA对照组(n = 56)的血清MBL浓度。MBL2基因型分布符合Hardy-Weinberg平衡。重要的是,与无菌TJA对照组相比,PJI患者中MBL2 -550 L等位基因(等位基因频率,0.72)和LL基因型(基因型频率,0.51)更常见(L等位基因:0.63,P = 0.016, P(c) = 0.048;LL基因型:0.39,P = 0.037, P(c) > 0.05)和捷克人群对照(L等位基因:0.61,P = 0.010, P(c) = 0.030;LL基因型分别为0.35,P = 0.006, P(c) = 0.018。关于MBL蛋白,MBL2 -550 L携带者的血清MBL浓度低于非携带者(中位数;593 vs 1876 ng/ml;P < 0.01)。同样,携带MBL2 -221 X和54a等位基因与血清MBL浓度降低相关(P < 0.01)。综上所述,MBL2 -550基因变异与低血清MBL蛋白浓度相关,可增加PJI的发病风险。
{"title":"MBL2 gene variation affecting serum MBL is associated with prosthetic joint infection in Czech patients after total joint arthroplasty.","authors":"Z Navratilova,&nbsp;J Gallo,&nbsp;F Mrazek,&nbsp;J Lostak,&nbsp;M Petrek","doi":"10.1111/tan.12001","DOIUrl":"https://doi.org/10.1111/tan.12001","url":null,"abstract":"<p><p>Prosthetic joint infection (PJI) is a serious complication of the total joint arthroplasty (TJA). Serum mannose-binding lectin (MBL), a pattern recognition receptor, is involved in antibacterial immune response. This study investigated whether functional variants of the MBL2 gene may be associated with the risk of PJI. MBL2 -550 (H/L, rs11003125), MBL2 -221 (Y/X, rs7096206) and MBL2 +54 (G/A, rs1800450) single nucleotide polymorphisms (SNP) were genotyped in 112 PJI patients and two control groups: 245 patients with aseptic TJA and 196 Czech population controls without TJA. Serum MBL concentration was assessed in PJI patients (n = 92) and aseptic TJA controls (n = 56). The distribution of MBL2 genotypes complied with the Hardy-Weinberg equilibrium in all investigated groups. Importantly, MBL2 -550 L allele (allelic frequency, 0.72) and LL genotype (genotype frequency, 0.51) were more frequent among PJI patients compared to aseptic TJA controls (L allele: 0.63, P = 0.016, P(c) = 0.048; LL genotype: 0.39, P = 0.037, P(c) > 0.05) and to Czech population controls (L allele: 0.61, P = 0.010, P(c) = 0.030; LL genotype: 0.35, P = 0.006, P(c) = 0.018), respectively. Regarding MBL protein, the MBL2 -550 L carriers presented with lower serum MBL concentrations than non-carriers (median; 593 vs 1876 ng/ml; P < 0.01). Similarly, the carriage of MBL2 -221 X and 54 A alleles was associated with lower serum MBL concentrations (P < 0.01). In conclusion, MBL2 -550 genetic variant(s) associated with low serum concentration of MBL protein can increase the risk of PJI.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"444-51"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/tan.12001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30918469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study. 汉族儿童HLA-B基因与桥本病:一项病例对照和基于家庭的研究
Pub Date : 2012-11-01 DOI: 10.1111/tan.12003
C-Y Huang, T-Y Chang, C-C Chu, F-S Lo, W-H Ting, C-H Lin, Y-L Wu, S-Y Chu, S-C Chang, W-F Chen, C-L Lin, W-S Lin, Y-J Lee

Hashimoto disease (HD) is an autoimmune thyroid disease resulting from complex interactions between genetic and environmental factors. The human leukocyte antigen (HLA) gene has been established to be involved in the susceptibility to HD. We aim to investigate the associations between HLA-B alleles and Han Chinese children with HD by both case-control and family-based studies. A total of 108 unrelated children with HD, 380 unrelated healthy controls, 58 trios of affected patients and their parents, and 75 trios of unaffected siblings and their parents were recruited. HLA-B genotyping was performed by polymerase chain reaction and detected with a sequence-specific oligonucleotide probes system. We found that B*46:01 allele (OR = 2.31, 95% CI 1.60-3.34, P(c) = 9.99 × 10(-5)) and carrier (OR = 3.28, 95% CI 2.10-5.11, P(c) = 1.35 × 10(-6)) were associated with HD risk. Transmission/disequilibrium test further confirmed an overtransmission of the B*46:01 (OR 2.55, 95% CI 1.36-6.10, P = 6.5 × 10(-3)). The findings were similar in females when stratified by gender. In conclusion, our results clearly identify that HLA-B*46:01 confers susceptibility to HD in Han Chinese children. Further studies with larger children cohort are required to confirm the role of B*46:01 in the development of HD.

桥本病(HD)是一种由遗传和环境因素复杂相互作用引起的自身免疫性甲状腺疾病。人类白细胞抗原(HLA)基因已被证实与HD易感性有关。我们的目的是通过病例对照和基于家庭的研究来调查HLA-B等位基因与汉族儿童HD之间的关系。总共招募了108名无血缘关系的HD患儿,380名无血缘关系的健康对照,58组受影响的患者及其父母,75组未受影响的兄弟姐妹及其父母。采用聚合酶链反应进行HLA-B基因分型,并采用序列特异性寡核苷酸探针系统进行检测。我们发现B*46:01等位基因(OR = 2.31, 95% CI 1.60-3.34, P(c) = 9.99 × 10(-5))和携带者(OR = 3.28, 95% CI 2.10-5.11, P(c) = 1.35 × 10(-6))与HD风险相关。传播/不平衡试验进一步证实了B*46:01的过度传播(OR 2.55, 95% CI 1.36-6.10, P = 6.5 × 10(-3))。在按性别分层的女性中,研究结果也相似。总之,我们的研究结果清楚地表明,HLA-B*46:01与汉族儿童HD易感性有关。B*46:01基因在HD发病中的作用需要进一步的研究来证实。
{"title":"The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study.","authors":"C-Y Huang,&nbsp;T-Y Chang,&nbsp;C-C Chu,&nbsp;F-S Lo,&nbsp;W-H Ting,&nbsp;C-H Lin,&nbsp;Y-L Wu,&nbsp;S-Y Chu,&nbsp;S-C Chang,&nbsp;W-F Chen,&nbsp;C-L Lin,&nbsp;W-S Lin,&nbsp;Y-J Lee","doi":"10.1111/tan.12003","DOIUrl":"https://doi.org/10.1111/tan.12003","url":null,"abstract":"<p><p>Hashimoto disease (HD) is an autoimmune thyroid disease resulting from complex interactions between genetic and environmental factors. The human leukocyte antigen (HLA) gene has been established to be involved in the susceptibility to HD. We aim to investigate the associations between HLA-B alleles and Han Chinese children with HD by both case-control and family-based studies. A total of 108 unrelated children with HD, 380 unrelated healthy controls, 58 trios of affected patients and their parents, and 75 trios of unaffected siblings and their parents were recruited. HLA-B genotyping was performed by polymerase chain reaction and detected with a sequence-specific oligonucleotide probes system. We found that B*46:01 allele (OR = 2.31, 95% CI 1.60-3.34, P(c) = 9.99 × 10(-5)) and carrier (OR = 3.28, 95% CI 2.10-5.11, P(c) = 1.35 × 10(-6)) were associated with HD risk. Transmission/disequilibrium test further confirmed an overtransmission of the B*46:01 (OR 2.55, 95% CI 1.36-6.10, P = 6.5 × 10(-3)). The findings were similar in females when stratified by gender. In conclusion, our results clearly identify that HLA-B*46:01 confers susceptibility to HD in Han Chinese children. Further studies with larger children cohort are required to confirm the role of B*46:01 in the development of HD.</p>","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"80 5","pages":"431-6"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/tan.12003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30940105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
期刊
Tissue antigens
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1